Lipoprotein risk factors for cardiovascular disease in patients with type 2 diabetes mellitus treated with oral antihyperglycaemic agents

被引:1
作者
Chu, JW
Abbasi, F
McLaughlin, TL
Lamendola, C
Schaaf, P
Carlson, TH
Leary, ET
Reaven, GM [1 ]
机构
[1] Stanford Univ, Med Ctr, Falk CVRB, Sch Med,Dept Med, Stanford, CA 94305 USA
[2] Pacific Biometr Inc, Seattle, WA USA
关键词
cardiovascular disease; dyslipidemia; metformin; sulphonylurea; type 2 diabetes mellitus;
D O I
10.1046/j.1463-1326.2003.00284.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: To compare lipoprotein risk factors for cardiovascular disease (CVD) in patients with type 2 diabetes mellitus (DM) treated with a sulphonylurea (SU) compound only, metformin (MET) only, or combined SU+MET. Methods: The study population consisted of 62 patients with type 2 DM, whose antihyperglycaemic treatment program had been stable for at least 3 months, divided into three groups: 26 patients in the SU group, 17 patients in the MET group and 19 patients in the SU+MET group. None of the patients were taking lipid-lowering drugs. Fasting venous blood samples were taken to measure concentrations of glucose, total cholesterol, triglycerides (TG), high-density lipoprotein-cholesterol (HDL-C), low-density lipoprotein-cholesterol (LDL-C) and remnant lipoprotein-cholesterol (RLP-C) as well as for determination of LDL particle diameter. Results: The three groups were similar in terms of age, gender, body mass index and fasting plasma glucose concentrations. Total cholesterol concentrations were significantly lower (p < 0.05 for trend) in those treated with SU+MET as compared with the other two groups. However, there were no significant differences between the three groups in their plasma concentrations of TG, LDL-C, HDL-C or RLP-C; furthermore, the proportion of individuals within each treatment group with small LDL particle diameter was also not different. Conclusions: The lipoprotein profile of patients with type 2 DM, matched for level of fasting hyperglycaemia, was similar irrespective of treatment with SU alone, MET alone or SU+MET. Thus, we could not identify any changes in lipoprotein metabolism that could account for differences in risk of CVD as a function of treatment.
引用
收藏
页码:333 / 337
页数:5
相关论文
共 50 条
[21]   Identification of Risk Factors for Coronary Artery Disease in Asymptomatic Patients with Type 2 Diabetes Mellitus [J].
Takamura, Kazuhisa ;
Fujimoto, Shinichiro ;
Mita, Tomoya ;
Kawaguchi, Yuko Okano ;
Kurita, Mika ;
Kadowaki, Satoshi ;
Kamo, Yuki ;
Aoshima, Chihiro ;
Nozaki, Yui Okada ;
Takahashi, Daigo ;
Kudo, Ayako ;
Hiki, Makoto ;
Tomizawa, Nobuo ;
Ikeda, Fuki ;
Satoh, Hiroaki ;
Watada, Hirotaka ;
Minamino, Tohru .
JOURNAL OF CLINICAL MEDICINE, 2022, 11 (05)
[22]   Nomogram Based on Risk Factors for Type 2 Diabetes Mellitus Patients with Coronary Heart Disease [J].
Shi, Rong ;
Wu, Birong ;
Niu, Zheyun ;
Sun, Hui ;
Hu, Fan .
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2020, 13 :5025-5036
[23]   Increasing awareness of hypoglycaemia in patients with Type 2 diabetes treated with oral agents [J].
Barnett, A. H. ;
Brice, R. ;
Hanif, W. ;
James, J. ;
Langerman, H. .
CURRENT MEDICAL RESEARCH AND OPINION, 2013, 29 (11) :1503-1513
[24]   Lipoprotein(a) concentrations in patients with type 2 diabetes mellitus without cardiovascular disease:: relationship to metabolic parameters and diabetic complications [J].
Tarkun, I ;
Çetinarslan, B ;
Cantürk, Z .
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2002, 12 (03) :127-131
[25]   Cardiovascular Disease in Diabetes Mellitus Risk Factors and Medical Therapy [J].
Szuszkiewicz-Garcia, Magdalene M. ;
Davidson, Jaime A. .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2014, 43 (01) :25-+
[26]   Cardiovascular risk in the spectrum of type 2 diabetes mellitus [J].
Ahmed, Intekhab ;
Goldstein, Barry J. .
MOUNT SINAI JOURNAL OF MEDICINE, 2006, 73 (05) :759-768
[27]   Smoking behavior change and risk of cardiovascular disease incidence and mortality in patients with type 2 diabetes mellitus [J].
Su-Min Jeong ;
Jung Eun Yoo ;
Junhee Park ;
Wonyoung Jung ;
Kyu Na Lee ;
Kyungdo Han ;
Cheol Min Lee ;
Ki-Woong Nam ;
Seung-Pyo Lee ;
Dong Wook Shin .
Cardiovascular Diabetology, 22
[28]   Smoking behavior change and risk of cardiovascular disease incidence and mortality in patients with type 2 diabetes mellitus [J].
Jeong, Su-Min ;
Yoo, Jung Eun ;
Park, Junhee ;
Jung, Wonyoung ;
Lee, Kyu Na ;
Han, Kyungdo ;
Lee, Cheol Min ;
Nam, Ki-Woong ;
Lee, Seung-Pyo ;
Shin, Dong Wook .
CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
[29]   Evaluation of Cardiovascular Disease Risk in Patients with Type 2 Diabetes Mellitus Using Clinical Laboratory Markers [J].
Ulambayar, Battamir ;
Ghanem, Amr Sayed ;
Chau, Nguyen Minh ;
Faludi, Eszter Vargane ;
More, Marianna ;
Nagy, Attila Csaba .
JOURNAL OF CLINICAL MEDICINE, 2024, 13 (12)
[30]   Lipoprotein(a) as a Higher Residual Risk for Coronary Artery Disease in Patients with Type 2 Diabetes Mellitus than without [J].
Yu, Bingyan ;
Hu, Xiangming ;
Liu, Jieliang ;
Nie, Zhiqiang ;
Bu, Ci Ren Luo ;
Li, Guang ;
Zhou, Yingling ;
Dong, Haojian .
INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2023, 16 :3383-3391